MedTrace Logo

Impact of Sperm DNA Integrity on Artificial Reproductive Treatment (ART)

NCT00875095 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 8

Last updated 2016-09-08

No results posted yet for this study

Summary

The purpose of this study is to establish a new criteria with which to judge the quality of sperm samples submitted for artificial reproductive treatments. It is believed that this type of testing can compliment the traditional semen analysis to better drive patient care.

Conditions

  • Sperm DNA Impact on ART Outcomes

Sponsors & Collaborators

  • Organon

    collaborator INDUSTRY

  • Northwell Health

    lead OTHER

Principal Investigators

  • Avner Hershlag, MD · Northwell Health

  • Dennis E Marchesi, MSc · Northwell Health

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-10-31
Primary Completion
2008-12-31
Completion
2008-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00875095 on ClinicalTrials.gov